Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors: Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, Ann Belmans, Geert Verbeke, Peter Verhamme, Robin Vos, W. Janssens, on behalf of the DAWn-Azithro consortium
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Trials
Online Access:https://doi.org/10.1186/s13063-021-05153-4

Internet

https://doi.org/10.1186/s13063-021-05153-4

Similar Items